[1]AL-KHAIFI A,STRANIER S,VORONOBA V,et al.Asynchronous rhythms of circulating conjugated and unconjugated bile acids in the modulation of human metabolism[J].J Intern Med,2018,2845:546-559.
[2]LIU Y,CAO M,CAI Y,et al.Dissecting the role of the FGF19-FGFR4 signaling pathway in cancer development and progression[J].Front Cell Dev Biol,2020,8:95.
[3]王婷,王燕,彭朵,等.慢病毒载体构建成纤维生长因子19过表达大肠癌细胞系及其对大肠癌细胞迁移活性的影响[J].中国临床药理学杂志,2022,38(23):2850-2854.
WANG T,WANG Y,PENG D,et al.Establishment of FGF19 overexpressed colorectal cancer cell lines constructed by lentiviral vector and effect on migration of colorectal cancer cells [J].Chinese Journal of Clinical Pharmacology,2022,38(23):2850-2854.
[4]王军成,兰彦平,赵岳阳,等.LINK-A RNAi慢病毒载体构建及其抑制U251胶质瘤细胞增殖的研究[J].宁夏医学杂志,2023,45(07):577-580,572.
WANG JC,LAN YP,ZHAO YY,et al.Study of LINK-A RNAi lentiviral vector construction and its inhibition of U251 glioma cell proliferation [J].Ningxia Medical Journal,2023,45(07):577-580,572.
[5]曹维维,袁成良.人类白细胞抗原-G5过表达慢病毒载体的构建以及JAR-HLA-G5稳转细胞株的建立[J].中国临床药理学杂志,2021,37(18):2495-2498.
CAO WW,YUAN CL.Construction of human leukocyte antigen-G5 overexpression lentiviral vectors and establishment of JAR-HLA-G5 stable cell lines [J].Chinese Journal of Clinical Pharmacology,2021,37(18):2495-2498.
[6]刘献菊,谢亚亚,曹丽君,等.miR-151a-5p对结直肠癌细胞增殖和转移的影响及其机制探讨[J].现代肿瘤医学,2023,31(17):3139-3144.
LIU XJ,XIE YY,CAO LJ,et al.Effect of miR-151a-5p on proliferation and metastasis of colorectal cancer cells and its mechanism [J].Modern Oncology,2023,31(17):3139-3144.
[7]BABAKNEJA N,NAYERI H,HEMMAT R,et al.An overview of FGF19 and FGF21:The therapeutic role in the treatment of the metabolic disorders and obesity[J].Horm Metab Res,2018,506:441-452.
[8]LI X.The FGF metabolic axis[J].Front Med,2019,135:511-530.
[9]王磊,陈欣菊.FGF19/FGFR4信号通路在肝细胞癌中的研究进展[J].现代肿瘤医学,2019,27(16):2949-2954.
WANG L,CHEN XJ.Research progress of FGF19/FGFR4 signaling pathway in hepatocellular carcinoma[J].Modern Oncology,2019,27(16):2949-2954.
[10]PRIETO-DOMINGUE N,SHULL AY,TENG Y.Making way for suppressing the FGF19/FGFR4 axis in cancer[J].Future Med Chem,2018,1020:2457-2470.
[11]RYAN KK,KOHLI R,GUTIERREZ-AGUILAR R,et al.Fibroblast growth factor-19 action in the brain reduces food intake and body weight and improves glucose tolerance in male rats[J].Endocrinology,2013,154(1):9-15.
[12]WANG H,VENKATESH M,LI H,et al.Pregnane X receptor activation induces FGF19-dependent tumor aggressiveness in humans and mice[J].J Clin Invest,2011,121(8):3220-3232.
[13]ZHANG Y,WU T,LI F,et al.FGF19 Is Coamplified with CCND1 to promote proliferation in lung squamous cell carcinoma and their combined inhibition shows improved efficacy[J].Front Oncol,2022,12:846744.
[14]LI Y,ZHANG W,DOUGHTI A,et al.Up-regulation of fibroblast growth factor 19 and its receptor associates with progression from fatty liver to hepatocellular carcinoma[J].Oncotarget,2016,7(32):52329-52339.
[15]DESNOYER LR,PAI R,FERRAND RE,et al.Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models[J].Oncogene,2008,27(1):85-97.
[16]FERNANDEZ-PONCE C,GERIBALDI-DOLDAN N,SANCHEZ-GOMAR I,et al.The role of glycosyltransferases in colorectal cancer[J].Int J Mol Sci,2021,22(11):5822.